Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
3(17%)
Results Posted
0%(0 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
3
17%
Ph early_phase_1
1
6%
Ph not_applicable
13
72%
Ph phase_2
1
6%

Phase Distribution

4

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
3(16.7%)
Phase 2Efficacy & side effects
1(5.6%)
N/ANon-phased studies
13(72.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

18

all time

Status Distribution
Active(3)
Completed(12)
Terminated(1)
Other(2)

Detailed Status

Completed12
Recruiting2
unknown2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
3
Success Rate
92.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.6%)
Phase 13 (16.7%)
Phase 21 (5.6%)
N/A13 (72.2%)

Trials by Status

active_not_recruiting16%
completed1267%
recruiting211%
unknown211%
terminated16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials

All 18 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
18